Cargando…

COPD exacerbations: defining their cause and prevention

Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are associated with increased airway and systemic inflammation and physiological changes, especially the development of hyperinflati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wedzicha, Jadwiga A, Seemungal, Terence AR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134993/
https://www.ncbi.nlm.nih.gov/pubmed/17765528
http://dx.doi.org/10.1016/S0140-6736(07)61382-8
_version_ 1783517954748448768
author Wedzicha, Jadwiga A
Seemungal, Terence AR
author_facet Wedzicha, Jadwiga A
Seemungal, Terence AR
author_sort Wedzicha, Jadwiga A
collection PubMed
description Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are associated with increased airway and systemic inflammation and physiological changes, especially the development of hyperinflation. They are triggered mainly by respiratory viruses and bacteria, which infect the lower airway and increase airway inflammation. Some patients are particularly susceptible to exacerbations, and show worse health status and faster disease progression than those who have infrequent exacerbations. Several pharmacological interventions are effective for the reduction of exacerbation frequency and severity in COPD such as inhaled steroids, long-acting bronchodilators, and their combinations. Non-pharmacological therapies such as pulmonary rehabilitation, self-management, and home ventilatory support are becoming increasingly important, but still need to be studied in controlled trials. The future of exacerbation prevention is in assessment of optimum combinations of pharmacological and non-pharmacological therapies that will result in improvement of health status, and reduction of hospital admission and mortality associated with COPD.
format Online
Article
Text
id pubmed-7134993
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71349932020-04-08 COPD exacerbations: defining their cause and prevention Wedzicha, Jadwiga A Seemungal, Terence AR Lancet Review Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are associated with increased airway and systemic inflammation and physiological changes, especially the development of hyperinflation. They are triggered mainly by respiratory viruses and bacteria, which infect the lower airway and increase airway inflammation. Some patients are particularly susceptible to exacerbations, and show worse health status and faster disease progression than those who have infrequent exacerbations. Several pharmacological interventions are effective for the reduction of exacerbation frequency and severity in COPD such as inhaled steroids, long-acting bronchodilators, and their combinations. Non-pharmacological therapies such as pulmonary rehabilitation, self-management, and home ventilatory support are becoming increasingly important, but still need to be studied in controlled trials. The future of exacerbation prevention is in assessment of optimum combinations of pharmacological and non-pharmacological therapies that will result in improvement of health status, and reduction of hospital admission and mortality associated with COPD. Elsevier Ltd. 2007 2007-08-30 /pmc/articles/PMC7134993/ /pubmed/17765528 http://dx.doi.org/10.1016/S0140-6736(07)61382-8 Text en Copyright © 2007 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Wedzicha, Jadwiga A
Seemungal, Terence AR
COPD exacerbations: defining their cause and prevention
title COPD exacerbations: defining their cause and prevention
title_full COPD exacerbations: defining their cause and prevention
title_fullStr COPD exacerbations: defining their cause and prevention
title_full_unstemmed COPD exacerbations: defining their cause and prevention
title_short COPD exacerbations: defining their cause and prevention
title_sort copd exacerbations: defining their cause and prevention
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134993/
https://www.ncbi.nlm.nih.gov/pubmed/17765528
http://dx.doi.org/10.1016/S0140-6736(07)61382-8
work_keys_str_mv AT wedzichajadwigaa copdexacerbationsdefiningtheircauseandprevention
AT seemungalterencear copdexacerbationsdefiningtheircauseandprevention